Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01995175 · ClinicalTrials.gov registry record · NA
A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age
A NA study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- NA
- Development phase
- 2,409
- Enrollment target
NCT01995175 is a NA study that has completed, run by GlaxoSmithKline. The registered enrollment target is 2,409 participants.
The verdict
NCT01995175, a NA study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,409 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the incidence and associated healthcare utilization of RSV-associated, suspected LRTI in a general population of infants from birth up to 2 years of age, and also to assess the accuracy of a newly developed LRTI case definition and severity scale compared to two existing definitions. The study will also assess the population attributable risk percent of RSV LRTI on the development of wheeze and asthma from 0 to 6 years of age.
Interventions
- PROCEDURE Blood sampling
- PROCEDURE Nasal swab sampling
- OTHER Diary cards
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,409 participants |
| Start Date | 2013-12-12 |
| Est. Completion | 2021-11-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01995175
The ClinicalTrials.gov registry entry for NCT01995175 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,409 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Blood sampling is the first listed.
NCT01995175 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01995175 about?
NCT01995175 is a clinical study titled "A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age". The purpose of this study is to assess the incidence and associated healthcare utilization of RSV-associated, suspected LRTI in a general population of infants from birth up to 2 years of age, and also to assess the accuracy of a newly developed LRTI case definition and severity scale compared to tw...
What is the current status of trial NCT01995175?
This trial is currently completed. It is a NA study. The enrollment target is 2,409 participants. The study started on 2013-12-12. Estimated completion is 2021-11-03.
What interventions are being tested in trial NCT01995175?
The interventions under investigation include: Blood sampling (PROCEDURE), Nasal swab sampling (PROCEDURE), Diary cards (OTHER).
Who is sponsoring clinical trial NCT01995175?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.